Address
Seestrasse 16
Kusnacht, 8700
Switzerland
Phone
41 44 267 67 00
Sector
Healthcare
Industry
Biotechnology
Employees
10
First IPO Date
June 29, 2020
| Name | Title | Pay | Year Born |
| Daniel Koller | Head of Biotech, Portfolio Manager and Member of Executive Board | 0 | 1970 |
BB Biotech AG functions as an equity investment vehicle, managed by Bellevue Asset Management AG. Its investment mandate extends to publicly traded companies across the globe, with a particular focus on firms engaged in modern biotechnology for medications and diagnostic tools. The construction of its portfolio is driven by a rigorous fundamental analysis. This Swiss-domiciled entity was established on November 9, 1993.